The Latest Headlines at Markets Daily
Insider Selling: Kestra Medical Technologies (NASDAQ:KMTS) Insider Sells $311,366.64 in Stock
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS – Get Free Report) insider Brian Daniel Webster sold 13,017 shares of the company’s stock in a transaction dated Monday, August 3rd. The shares were sold at an average price... More of this article »
Lisa Lynn Daniels Sells 30 Shares of Cavco Industries (NASDAQ:CVCO) Stock
Cavco Industries, Inc. (NASDAQ:CVCO – Get Free Report) Director Lisa Lynn Daniels sold 30 shares of Cavco Industries stock in a transaction dated Thursday, July 30th. The stock was sold at an average price of $569.96, for a total... More of this article »
Gloo (NASDAQ:GLOO) Major Shareholder Financial For Luthera Thrivent Sells 21,000 Shares
Gloo Holdings (NASDAQ:GLOO – Get Free Report) major shareholder Financial For Luthera Thrivent sold 21,000 shares of the company’s stock in a transaction that occurred on Monday, August 3rd. The shares were sold at an average... More of this article »
Kestra Medical Technologies (NASDAQ:KMTS) Insider Sells $133,870.38 in Stock
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS – Get Free Report) insider Traci Umberger sold 5,887 shares of the firm’s stock in a transaction that occurred on Thursday, July 30th. The stock was sold at an average price... More of this article »
AptarGroup (NYSE:ATR) Insider Hedi Tlili Sells 8,854 Shares
AptarGroup, Inc. (NYSE:ATR – Get Free Report) insider Hedi Tlili sold 8,854 shares of the business’s stock in a transaction that occurred on Monday, August 3rd. The stock was sold at an average price of $135.00, for a total... More of this article »
Recent Analysts’ Ratings Changes for Twilio (TWLO)
A number of firms have modified their ratings and price targets on shares of Twilio (NYSE: TWLO) recently: 7/28/2026 – Twilio had its price target raised by BTIG Research from $215.00 to $245.00. They now have a “buy”... More of this article »
Analyzing UWM (NYSE:UWMC) and Forge Global (NYSE:FRGE)
UWM (NYSE:UWMC – Get Free Report) and Forge Global (NYSE:FRGE – Get Free Report) are both finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, dividends,... More of this article »
Head-To-Head Review: Artis Real Estate Investment Trust (OTCMKTS:ARESF) vs. Presidio Property Trust (NASDAQ:SQFT)
Presidio Property Trust (NASDAQ:SQFT – Get Free Report) and Artis Real Estate Investment Trust (OTCMKTS:ARESF – Get Free Report) are both real estate companies, but which is the better business? We will contrast the two... More of this article »
Champion Real Estate Investment Trust (CMPNF) & Its Competitors Financial Review
Dividends Champion Real Estate Investment Trust pays an annual dividend of $0.11 per share and has a dividend yield of 32.3%. Champion Real Estate Investment Trust pays out -149.0% of its earnings in the form of a dividend. As a group,... More of this article »
Contrasting EastGroup Properties (NYSE:EGP) & SEGRO (OTCMKTS:SEGXF)
EastGroup Properties (NYSE:EGP – Get Free Report) and SEGRO (OTCMKTS:SEGXF – Get Free Report) are both large-cap real estate companies, but which is the better stock? We will contrast the two businesses based on the strength... More of this article »
Comparing Divestco (OTCMKTS:DSVTF) & Oceaneering International (NYSE:OII)
Oceaneering International (NYSE:OII – Get Free Report) and Divestco (OTCMKTS:DSVTF – Get Free Report) are both energy companies, but which is the superior stock? We will contrast the two companies based on the strength... More of this article »-company-of-china-ltd-logo-1200x675.jpg){kind=logo}
Head-To-Head Survey: Ping An Insurance (Group) Company of China (PIAIF) and Its Peers
Profitability This table compares Ping An Insurance (Group) Company of China and its rivals’ net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets Ping An Insurance (Group) Company... More of this article »
Jazz Pharmaceuticals (NASDAQ:JAZZ) Posts Quarterly Earnings Results, Misses Estimates By $0.47 EPS
Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Free Report) posted its quarterly earnings data on Monday. The specialty pharmaceutical company reported $5.71 earnings per share (EPS) for the quarter, missing the consensus estimate of... More of this article »